Stock Evaluator: BillionToOne, Inc. (BLLN)

BillionToOne, Inc. BLLN

$89.92 -0.28 -0.31%
November 20, 2026 4:00:00 PM EST November 10, 2021 Volume: 819,341
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Providers & Services

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection. It also offers UNITY Complete, a non-invasive prenatal screen that assesses fetal risk for aneuploidies, recessive conditions, and fetal antigens from a maternal blood draw; Northstar Select, a liquid biopsy test that provides a list of mutations that are present in the tumor and types of mutations detected that include deletions, insertions, and point mutations; and Northstar Response, a methylation-based assay that quantifies the amount of cancer at the single molecule level without requiring a tissue biopsy, enabling real-time monitoring of patient response to therapy with unprecedented precision. BillionToOne, Inc. was incorporated in 2016 and is headquartered in Menlo Park, California.

Commentary & Analysis


Financial Summary

Share Statistics BLLN Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $4,295.9 $1,721.2 67%
Shares Out (Mil) 53.7 80.6 49%
Institutional Ownership 80.0% 87.6% 48%
Float (Mil) 29.3 59.2 35%
Beta na 0.74 na
Avg Daily Volume (000s) 861 613 67%
Price Change
(52-week)
(7.5%) 74.5% 47%
Growth BLLN Industry
Median
Percentile
(All Stocks)
Sales (5yr) na 10.4% na
Net Income (5yr) na (0.5%) na
EPS (5yr) na 3.0% na
Dividends (5yr) na 0.0% 0%
Cash Flow (5yr) na (17.4%) na
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 1 1 2
Current EPS $0.250 $1.620 $1.570
Month Ago EPS $0.305 $1.495 $1.485
# Rev Up 0 0 0
# Rev Down 0 0 1
Three Months Ago EPS $0.250 $1.390 $1.330
Year/Year Chg (21.9%) 1,057% 1,521%
Financials BLLN Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $437 $1,529 39%
Net Income (TTM) (Mil) $46 $33 53%
EPS (TTM) $1.069 $0.300 61%
Operating Cash Flow (TTM) (Mil) $48 $175 46%
Net Cash Flow (TTM) (Mil) $366 $7 89%
Long-Term Debt (Q1) (Mil) $133 $419 46%
Enterprise Value (Q1) (Mil) $4,603 $2,427 62%
Valuation BLLN Industry
Median
Percentile
(All Stocks)
P/B 7.58 2.56 90%
P/E 98.3 25.9 95%
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.1 na
Ratios BLLN Industry
Median
Percentile
(All Stocks)
Gross Margin 71.4% 27.3% 82%
Net Margin 10.5% 1.4% 63%
ROA 8.4% 2.4% 83%
ROE 28.1% 7.3% 86%
Liabilities to Assets 25.5% 62.3% 17%
F-Score 4 5 33%

Passing Stock Screens

As of 11/20/2026, from a list of 60 stock screening strategies, BLLN meetings the criteria of 1 screen:

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors